Neuroendocrine Tumors
📧 Sign up to get email alerts when something new happens for Neuroendocrine Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer [Phase 2]
Phase 2 clinical trial evaluating autologous T cells engineered to express T-cell receptors against neoantigens in metastatic cancer, curren…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma [Phase 2]
A Phase 2 clinical trial evaluating Lutathera (Lutetium-177 DOTATATE) for inoperable pheochromocytoma and paraganglioma is currently recruit…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Ultralow Dose PET Imaging of 18F-FDOPA [Phase 2]
Phase 2 trial evaluating ultralow-dose PET imaging with the radiotracer 18F-FDOPA in healthy volunteers and Parkinsonian syndromes to assess…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer [Phase 1, Phase 2]
A dose-defining study of tirapazamine combined with embolization in liver cancer (hepatocellular carcinoma) is in Phase 1/Phase 2 and curren…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Agnostic Therapy in Rare Solid Tumors [Phase 2]
A Phase 2 trial of an agnostic therapy for multiple rare solid tumors is currently recruiting. The study lists a broad set of tumor types ac…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed). [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating Lutathera (177Lu-DOTATATE) in combination with Olaparib for somatostatin receptor–expressing recurrent…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: A Study to Test How Well Different Doses of Obrixtamig (BI 764532) in Combination With Ezabenlimab Are Tolerated by People With Small Cell Lung Cancer and Other Neuroendocrine Tumours That Are Positive for DLL3 [Phase 1]
Phase 1 study evaluating tolerability of different doses of Obrixtamig (BI 764532) in combination with Ezabenlimab in patients with small ce…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Study of the Value of hPG80 (Circulating Progastrin) for the Diagnosis of Neuroendocrine Tumours in Patients With an MEN1 Mutation
This update describes a study evaluating circulating progastrin (hPG80) as a diagnostic biomarker for neuroendocrine tumors in patients with…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Peptide Receptor Radionuclide Therapy (PRRT) for the Treatment of Neuroendocrine Tumors
A clinical trial entry indicates that a study evaluating peptide receptor radionuclide therapy for neuroendocrine tumors is currently recrui…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Survival Without Persistent Limiting Toxicity: Real Life Prospective Cohort of Advanced Neuroendocrine Tumor
A real-world prospective cohort study in advanced neuroendocrine tumors evaluating survival without persistent limiting toxicity.
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Combination Immunotherapy in Rare Cancers Under InvesTigation [Phase 2]
This is a Phase 2 trial update describing a combination immunotherapy study for rare cancers; the trial is currently active but not recruiti…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Clinico-biological Database in Patients Treated With Metabolic Radiotherapy in the Nuclear Medicine Department [NA]
Clinical trial update describing a clinico-biological database for patients treated with metabolic radiotherapy in the Nuclear Medicine depa…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: F-Tryptophan PET/CT in Human Cancers [Phase 1]
A Phase 1 study evaluating F-Tryptophan PET/CT imaging across several cancers (intracranial glioma, metastatic brain tumor, breast cancer, n…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: DAREON™-7: A Study to Test How Well Different Doses of BI 764532 in Addition to Chemotherapy Are Tolerated by People With Advanced Neuroendocrine Cancers [Phase 1]
This clinical trial update describes a Phase 1 study evaluating the tolerability of BI 764532 in combination with chemotherapy in patients w…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Evaluation of Tolerance and Quality of Life in Patients With Neuroendocrine Tumors Treated With Oral Anti-Tumor Drugs Within a Therapeutic Education Program
A clinical trial protocol evaluating tolerance and quality of life in neuroendocrine tumors patients treated with oral anti-tumor drugs with…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: Lutathera and ASTX727 in Neuroendocrine Tumours [Phase 1]
Imperial College London is conducting a Phase 1 study evaluating Lutathera in combination with ASTX727 for neuroendocrine tumors, currently …
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: Lesion-to-lesion Comparison of 68Ga-HA-DOTATATE, 18F-DOPA, and 18F-FDG PET/CT in the Evaluation of Metastatic Neuroendocrine Tumors [Phase 2]
A Phase 2 clinical trial comparing lesion-to-lesion imaging using 68Ga-HA-DOTATATE, 18F-DOPA, and 18F-FDG PET/CT for evaluating metastatic n…
-
CLINICAL_TRIALS research · 2025-10-28Clinical Trial Update: A Study to Test How BI 764532 is Taken up by Tumours in People With Small-cell Lung Cancer or Neuroendocrine Cancer [Phase 1]
Phase 1 study to evaluate how the investigational cancer drug BI 764532 is taken up by tumors in people with small cell lung cancer or neuro…
-
CLINICAL_TRIALS research · 2025-10-10Clinical Trial Update: Imaging of Solid Tumors Using DLL3 SPECT [EARLY_Phase 1]
Early Phase 1 clinical trial evaluating DLL3 SPECT imaging for solid tumors, including castration-resistant prostate cancer and neuroendocri…
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: Tissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Cancer, Hepatocellular Cancer, Biliary Cancer, Neuroendocrine, Peritoneal Mesothelioma, Anal Cancer and Colorectal Cancer in Patients Undergoing Surgery or Biopsy
University of Chicago is recruiting for a tissue procurement study across multiple cancers in patients undergoing surgery or biopsy to colle…
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: A Study of BL-M14D1 in Patients With Locally Advanced or Metastatic Small Cell Lung Cancer, Neuroendocrine Tumors and Other Solid Tumors [Phase 1]
Phase 1 clinical trial evaluating BL-M14D1 in locally advanced or metastatic small cell lung cancer, neuroendocrine tumors, and other solid …
-
CLINICAL_TRIALS research · 2025-09-04Clinical Trial Update: A Long-term Safety Surveillance Study in Participants Previously Treated With 177Lu-IPN01072 [NA]
A long-term safety surveillance study of participants previously treated with 177Lu-IPN01072 has been completed, monitoring safety outcomes …
-
CLINICAL_TRIALS research · 2025-08-14Clinical Trial Update: Study of Acquired Resistance to Alkylator Chemotherapy in Endocrine Neoplasms
A clinical trial is investigating acquired resistance to alkylator chemotherapy in neuroendocrine tumors and endocrine cancers and is curren…
-
CLINICAL_TRIALS research · 2025-08-13Clinical Trial Update: Evaluate the Diagnostic Efficacy, Pharmacokinetics and Safety of 68Ga-DOTATATE Injection PET/CT in NETs [Phase 3]
Phase 3 trial evaluating diagnostic efficacy, pharmacokinetics, and safety of 68Ga-DOTATATE PET/CT for detecting neuroendocrine tumors; curr…
-
CLINICAL_TRIALS research · 2025-07-10Clinical Trial Update: A Phase III Clinical Study to Compare the Safety and Efficacy of 177Lu-DOTATATE Injection and Long-acting Oxytrexine in Adult Patients With NETs [Phase 3]
A Phase III trial comparing 177Lu-DOTATATE injections to long-acting Oxytrexine in adults with neuroendocrine tumors, currently recruiting.